Bruker Corporation is a leading global provider of scientific instruments and analytical solutions, catering primarily to the life sciences, materials research, and industrial sectors
The company specializes in advanced technologies that facilitate research and development, including mass spectrometry, nuclear magnetic resonance, infrared spectroscopy, and X-ray diffraction. Bruker’s innovative products are essential for a wide range of applications, from drug discovery and environmental monitoring to quality control and materials characterization. Committed to enhancing scientific research and diagnostic capabilities, Bruker supports researchers and industries by delivering precise and reliable data for improved decision-making and insights.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSEDHR) and the best and worst performers in the research tools & consumables industry.
Scientific instrument company Bruker (NASDAQBRKR). reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 14.6% year on year to $979.6 million. On the other hand, the company’s full-year revenue guidance of $3.51 billion at the midpoint came in 1.8% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 3.2% above analysts’ consensus estimates.
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally.
